alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
SCWC-29696

IN THE SUPREME COURT OF THE STATE OF HAWAI#I

DOUGLAS LEONE and PATRICIA A. PERKINS-LEONE, as Trustees under

that certain unrecorded Leone-Perkins Family Trust dated

August 26, 1999, as amended, Respondents/Plaintiffs-Appellants,

vs.

COUNTY OF MAUI, a political subdivision of the State of Hawai#i,

WILLIAM SPENCE, in his capacity as Director of the Department of

Planning of the County of Maui, Petitioners/Defendants-Appellees.

(CIV. NO. 07-1-0496)

and

WILLIAM L. LARSON and NANCY LARSON, as Trustees under that

certain unrecorded Larson Family Trust dated October 30-, 1992,

as amended, Respondents/Plaintiffs-Appellants,

vs.

COUNTY OF MAUI, a political subdivision of the State of Hawai#i,

WILLIAM SPENCE, in his capacity as Director of the Department of

Planning of the County of Maui, Petitioners/Defendants-Appellees.

(CIV. NO. 09-1-0413)

CERTIORARI TO THE INTERMEDIATE COURT OF APPEALS

(ICA NO. 29696; CIV. NOS. 07-1-0496 and 09-1-0413)

Electronically Filed

Supreme Court

SCWC-29696

12-DEC-2012

09:31 AM
ORDER REJECTING APPLICATION FOR WRIT OF CERTIORARI

(By: Recktenwald, C.J., Nakayama, Acoba, McKenna, and Pollack, JJ.)

Petitioners/Defendants-Appellees’ application for writ

of certiorari filed on October 29, 2012, is hereby rejected.

DATED: Honolulu, Hawai#i, December 12, 2012.

Patrick K. Wong and 

Mary Blaine Johnston

for petitioners

/s/ Mark E. Recktenwald

/s/ Paula A. Nakayama

/s/ Simeon R. Acoba, Jr.

/s/ Sabrina S. McKenna 

/s/ Richard W. Pollack

2
EXHIBIT
32
 
 
 CERTIFICATION
PURSUANT TO
 18 U.S.C
SECTION 1350
 AS
ADOPTED PURSUANT TO
 SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002
 
 
 In
connection with the Quarterly Report of Lescarden Inc. (the "Company") on Form
10-Q for the period ended February 28, 2009 as filed with the Securities and
Exchange Commission on the date hereof (the "Report"), I, William E. Luther,
certify, pursuant to 18 U.S.C. section 1350, as adopted pursuant to section 906
of Sarbanes-Oxley Act of 2002, that to the best of my knowledge:
 
 1.           The
Report fully complies with the requirements of section 13 (a) or 15 (d) of the
Securities Exchange Act of 1934, and
 
 2.           The
information contained in the Report fairly presents, in all material respects,
the financial condition and result of operations of the Company.
 
 
 /s/
William E. Luther
 William
E. Luther
 Chief
Executive Officer and Chief Financial Officer
 April 10,
2009
IN THE SUPREME COURT OF PENNSYLVANIA

MIDDLE DISTRICT

READING BLUE MOUNTAIN AND 

NORTHERN RAILROAD,

Petitioner

v.

SEDA-COG JOINT RAIL AUTHORITY AND 

BOARD OF SEDA-COG JOINT RAIL 

AUTHORITY, SUSQUEHANNA UNION 

RAILROAD COMPANY, AND CARLOAD 

EXPRESS, INC.,

Respondents

:

:

:

:

:

:

:

:

:

:

:

:

:

:

:

:

No. 432 MAL 2020

Petition for Allowance of Appeal 

from the Order of the 

Commonwealth Court

READING BLUE MOUNTAIN AND 

NORTHERN RAILROAD,

Petitioner

v.

SEDA-COG JOINT RAIL AUTHORITY AND 

BOARD OF SEDA-COG JOINT RAIL 

AUTHORITY, SUSQUEHANNA UNION 

RAILROAD COMPANY, AND CARLOAD 

EXPRESS, INC.,

Respondents

:

:

:

:

:

:

:

:

:

:

:

:

:

:

:

:

No. 433 MAL 2020

Petition for Allowance of Appeal 

from the Order of the 

Commonwealth Court

ORDER

PER CURIAM
[432 MAL 2020 and 433 MAL 2020] - 2

AND NOW, this 11th day of February, 2021, the Petition for Allowance of Appeal

is DENIED.
<TABLE> <S> <C>

<ARTICLE>                     5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM SEC FORM
10-Q AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS
</LEGEND>
<MULTIPLIER>                    1,000
       
<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                     JAN-31-1998
<PERIOD-START>                        AUG-03-1997
<PERIOD-END>                          NOV-01-1997
<CASH>                                      2,094
<SECURITIES>                                    0
<RECEIVABLES>                               6,685
<ALLOWANCES>                                    0
<INVENTORY>                                80,176
<CURRENT-ASSETS>                           88,955
<PP&E>                                    142,390
<DEPRECIATION>                           (72,321)
<TOTAL-ASSETS>                            202,164
<CURRENT-LIABILITIES>                      56,544
<BONDS>                                    95,000
<PREFERRED-MANDATORY>                           0
<PREFERRED>                                     0
<COMMON>                                       89
<OTHER-SE>                                 25,197
<TOTAL-LIABILITY-AND-EQUITY>              202,164
<SALES>                                   126,495
<TOTAL-REVENUES>                          126,495
<CGS>                                      86,030
<TOTAL-COSTS>                                   0
<OTHER-EXPENSES>                                0
<LOSS-PROVISION>                           30,053
<INTEREST-EXPENSE>                          3,278
<INCOME-PRETAX>                             4,188
<INCOME-TAX>                                4,188
<INCOME-CONTINUING>                            66
<DISCONTINUED>                                  0
<EXTRAORDINARY>                                 0
<CHANGES>                                       0
<NET-INCOME>                                4,122
<EPS-PRIMARY>                                0.45
<EPS-DILUTED>                                0.45
        

</TABLE>
Slip Op. 01-130
UNITED STATES COURT OF INTERNATIONAL TRADE
BEFORE: SENIOR JUDGE NICHOLAS TSOUCALAS

________________________________________________ : SKF USA INC., SKF FRANCE S.A., SARMA, : SKF GmbH, SKF INDUSTRIE S.p.A. and SKF : SVERIGE AB, : : Plaintiffs, : : v. : Court No. 98-07-02540 : UNITED STATES, : : Defendant, : : THE TORRINGTON COMPANY, : : Defendant-Intervenor. : ________________________________________:

ORDER

This matter comes before the Court pursuant to the decision of the Court of Appeals for the Federal Circuit (“CA FC”) in SKF USA Inc. v. United States , 263 F .3d 1 369 (Fed. Cir. 2001) and CAFC’s mandate of October 15, 2001, vacating and remanding the judgment of the Court in SKF USA Inc. v. United States , 2000 Ct. Intl. Trade LEXIS 61, Slip Op. 00-59 (CIT June 1, 2000). Pursuant to said decision by CAFC, this Court hereby
RE MANDS this case to the Department of Commerce, Internat iona l Trade Administration (“Commerce”) to: (1) p rovid e a reasonable explanation of why Commerce uses different definitions of “foreign like product” for price purposes and when calculating constructed value; (2) explain the factual setting for the calculations at issue; (3) explain the actual methodology of the calculations made; and(4) explain why Commerce’s methodology for the calculations of constructedvalue profit comports with the statute, the definition of “foreign like product” contained in 19 U.S.C. § 1677(16), and particularly the definition in subsection (C); and it is herebyCourt No. 98-07-02540 Page 2

ORDERED that the remand results are due within ninety (90) days of the date that this order is entered. Any responses or comments are due within thirty (30) days thereafter. Any rebuttal comments are due w ithin fifteen (15) days after the date the responses or comments are due.

_______________________ NICHOLAS TSOUCALAS SENIOR JUDGE

Dated: November 15, 2001

New York, New York
#### STATE v. MESSER

No. 165 PC

Case below: 49 NC App 691

Petition by defendant for discretionary review under G.S. 7A-31 denied 6 January 1981.
NOT FINAL UNTIL TIME EXPIRES TO FILE REHEARING MOTION AND, IF FILED, DETERMINED

IN THE DISTRICT COURT OF APPEAL OF FLORIDA SECOND DISTRICT HULON PONDER, III, ) ) Appellant, ) ) v. ) Case No. 2D18-52 ) STATE OF FLORIDA, ) ) Appellee. ) ___________________________________) Opinion filed May 23, 2018. Appeal pursuant to Fla. R. App. P. 9.141(b)(2) from the Circuit Court for Pinellas County; Michael F. Andrews, Judge.

PER CURIAM.

Affirmed. See Hatten v. State, 203 So. 3d 142 (Fla. 2016); Betancourt v. State, 804 So. 2d 313 (Fla. 2001); Kirkland v. State, 684 So. 2d 732 (Fla. 1996); State v. Whitehead, 472 So. 2d 730 (Fla. 1985); Robinson v. State, 37 So. 3d 921 (Fla. 2d DCA 2010); Burttram v. State, 846 So. 2d 1201 (Fla. 2d DCA 2003); Olsen v. State, 751 So. 2d 108 (Fla. 2d DCA 2000); State v. Richards, 639 So. 2d 680 (Fla. 2d DCA 1994); Chavers v. State, 115 So. 3d 1017 (Fla. 1st DCA 2013).

BLACK, SALARIO, and ROTHSTEIN-YOUAKIM, JJ., Concur.
<TABLE> <S> <C>

<ARTICLE>                                    5
<LEGEND> 
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM SEC FORM
10-Q AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS
</LEGEND>
<MULTIPLIER>                                 1000
       
<S>                                          <C>
<PERIOD-TYPE>                                3-MOS
<FISCAL-YEAR-END>                            JAN-30-1999
<PERIOD-START>                               AUG-02-1998
<PERIOD-END>                                 OCT-31-1998
<CASH>                                       1672
<SECURITIES>                                 0
<RECEIVABLES>                                6581
<ALLOWANCES>                                 0
<INVENTORY>                                  89702
<CURRENT-ASSETS>                             97955
<PP&E>                                       71011
<DEPRECIATION>                               0
<TOTAL-ASSETS>                               210983
<CURRENT-LIABILITIES>                        62419
<BONDS>                                      0
<PREFERRED-MANDATORY>                        0
<PREFERRED>                                  0
<COMMON>                                     90
<OTHER-SE>                                   10068
<TOTAL-LIABILITY-AND-EQUITY>                 210983
<SALES>                                      112005
<TOTAL-REVENUES>                             112005
<CGS>                                        74081
<TOTAL-COSTS>                                74081
<OTHER-EXPENSES>                             30450
<LOSS-PROVISION>                             0
<INTEREST-EXPENSE>                           3610
<INCOME-PRETAX>                              863
<INCOME-TAX>                                 33
<INCOME-CONTINUING>                          830
<DISCONTINUED>                               0
<EXTRAORDINARY>                              0
<CHANGES>                                    0
<NET-INCOME>                                 830
<EPS-PRIMARY>                                0.09
<EPS-DILUTED>                                0.09
        

</TABLE>
**Exhibit 23.1**

 

**CONSENT OF INDEPENDENT REGISTERED PUBLICACCOUNTING FIRM**

 

We hereby consent to the incorporation byreference in the registration statements (File Nos. 333-38690, 333-59310,333-59308, 333-64854, 333-87142, 333-96613 and 333-109831) on Form S-8 ofInterwave Communications International Ltd. of our report dated August 13,2004, except as to Note 19, which is as of October 4, 2004, relating to theconsolidated financial statements and financial statement schedule included inthis Annual Report of Form 10-K.

 

 
|   | /s/ BURR, PILGER & MAYER LLP |   |
|--------|----------------------------------|--------|

 

Palo Alto, CaliforniaOctober 11, 2004

 

----
II 

116TH CONGRESS 

1ST SESSION S. 2103 

To improve access to affordable insulin. 

IN THE SENATE OF THE UNITED STATES 

JULY 11, 2019 

Mr. DURBIN (for himself, Mr. CRAMER, and Ms. SMITH) introduced the following bill; which was read twice and referred to the Committee on 

Health, Education, Labor, and Pensions 

A BILL 

To improve access to affordable insulin. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Affordable Insulin Ap5 provals Now Act’’. 

6 SEC. 2. DEEMED APPROVAL UNDER SECTION 351. 

7 Section 7002(e)(4) of the Biologics Price Competition 

8 and Innovation Act of 2009 (Public Law 111–148) is 

9 amended— 

10 (1) by striking ‘‘An amended’’ and inserting the 

11 following: 


kjohnson on DSK79L0C42 with BILLS
2 

•S 2103 IS

1 ‘‘(A) IN GENERAL.—An amended’’; and 

2 (2) by adding at the end the following: 

3 ‘‘(B) TREATMENT OF CERTAIN PENDING

4 APPLICATIONS.—With respect to an application 

5 for an insulin biological product submitted 

6 under subsection (b)(2) or (j) of section 505 of 

7 the Federal Food, Drug, and Cosmetic Act (21 

8 U.S.C. 355) with a filing date that is not later 

9 than December 31, 2019, until the Secretary 

10 makes a determination on final approval with 

11 respect to such application, the Secretary shall 

12 continue to review and approve (as appropriate) 

13 such application under such section 505, even if 

14 such review and approval process continues 

15 after March 23, 2020. For purposes of com16 pleting the review and approval process for such 

17 an application, any listed drug referenced in the 

18 application shall be treated as a listed drug 

19 under section 505(j)(7) of the Federal Food, 

20 Drug, and Cosmetic Act, even if such listed 

21 drug is deemed licensed under section 351 of 

22 the Public Health Service Act during such re23 view and approval process. Effective on the 

24 later of March 23, 2020, or the date of ap25 proval under subsection (c) or (j) of section 505 


kjohnson on DSK79L0C42 with BILLS
3 

•S 2103 IS

1 of the Federal Food, Drug, and Cosmetic Act 

2 of any such application, such approved applica3 tion shall be deemed to be a license for the bio4 logical product under section 351 of the Public 

5 Health Service Act.’’. 

Æ 


kjohnson on DSK79L0C42 with BILLS
**Exhibit
      31.2**





**RULE
      13a-14(a)/15d-14(a) CERTIFICATIONS**





I, **Zhong
      Ya Li** , certify
      that:





1.  I
      have
      reviewed this Annual Report on Form 10-KSB of GFR Pharmaceuticals, Inc. (the
      “Company”).





2.  Based
      on
      my knowledge, this report does not contain any untrue statement of a material
      fact or omit to state a material fact necessary to make the statement made,
      in
      light of the circumstances under which such statements were made, not misleading
      with respect to the period covered by this report;





3.  Based
      on
      my knowledge, the financial statements, and other financial information included
      in this report, fairly present in all material respects, the financial
      condition, results of operations and cash flows of the Company as of, and for,
      the periods presented in this report;





4.  The
      Company’s other certifying officer(s) and I am responsible for establishing and
      maintaining disclosure controls and procedures (as defined in Exchange Act
      Rules
      13a-15d-15(e) and 15d-15(e)) for the Company and have:





(a)  Designed
      such disclosure controls and procedures, or caused such disclosure controls
      and
      procedures to be designed under our supervision, to ensure that material
      information relating to the Company, including its consolidates subsidiaries,
      is
      made known to us by others within those entities, particularly during the period
      in which this report is being prepared;





(b)  Evaluated
      the effectiveness of the Company’s disclosure controls and procedures, and
      presented in this report our conclusions about the effectiveness of the
      disclosure controls and procedures, as of the end of the period covered by
      this
      report based on such evaluation; and





(c)  Disclosed
      in this report any change in the Company’s internal control over financial
      reporting that occurred during the Company’s fourth fiscal quarter that has
      materially affected, or is reasonably likely to materially affect, the Company’s
      internal control over financial reporting; and





5.  The
      Company’s other certifying officer(s) and I have disclosed, based on our most
      recent evaluation of internal control over financial reporting, to the Company’s
      auditors and the audit committee of Company’s board of directors (or persons
      performing the equivalent functions):





(a)  All
      significant deficiencies and material weaknesses in the design or operation
      of
      internal control over financial reporting which are reasonably likely to
      adversely affect the Company’s ability to record, process, summarize and report
      financial information; and





(b)  Any
      fraud, whether or not material, that involves management or other employees
      who
      have a significant role in the Company’s
      internal control over financial reporting.





Date:
      April 29, 2008




By:/s/Zhong
                  Ya Li**Zhong Ya Li**
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Defense

###### Office of the Secretary

          - [Transmittal Nos. 08-09] 

# AGENCY:

Department of Defense, Defense Security Cooperation Agency.

# ACTION:

Notice. 

# SUMMARY:

The Department of Defense is publishing the unclassified text of a section 36(b)(1) arms sales notification. This is published to fulfill the requirements of section 155 of Public Law 104-164 dated 21 July 1996.

# FOR FURTHER INFORMATION CONTACT:

Ms. B. English, DSCA/DBO/CFM, (703) 601-3740.

The following is a copy of a letter to the Speaker of the House of Representatives, Transmittals 08-09 with attached transmittal, policy justification, and Sensitivity of Technology.

Dated: October 3, 2007.

L.M. Bynum,

OSD Federal Register Liaison Officer, Department of Defense.

      ( print page 57536)          ( print page 57537)          ( print page 57538)          ( print page 57539)    

BILLING CODE 5001-06-M

[FR Doc. 07-4974 Filed 10-9-07; 8:45 am]

BILLING CODE 5001-06-C
NO. 03 - 15 - 00109 - CR

Chelsea Podowski § IN THE THIRD COURT

v. § OF APPEALS
THE STATE OF TEXAS § AUSTIN , TEXAS

APPELLANT’S THIRD MOTION TO EXTEND TIME TO FILE BRIEF COMES NOW Chelsea Podowski, Appellant in the above-styled and numbered cause, by and through his undersigned counsel, and respectfully moves this Court to extend the time to file Appellant’s brief. In support thereof, and pursuant to T EX

. R. A PP

. P ROC . 10.5(b), Appellant would show as follows: (A) Appellant’s Brief is due on April 17 , 2 01 5; (B) Appellant seeks a 30 day extension; (C) Undersigned counsel has not had adequate time to review the record, research the law, and write a brief in this case. (D) One previous extensions have been granted. (E) Undersigned Counsel has had multiple jury trials to prepare for and has almost spent a week in trial last month.

WHEREFORE, PREMISES CONSIDERED, Appellant prays that the foregoing motion be GRANTED. ACCEPTED 03-15-00109-CR 5774068 THIRD COURT OF APPEALS

AUSTIN, TEXAS 6/22/2015 4:08:25 PM JEFFREY D. KYLE

CLERK2 Respectfully submitted,

/s/ James Gill

___________ JAMES GILL 1201 Rio Grande Street, Ste. 200 Austin, T exas 78701 (512) 448

- 4560 (512) 308

- 6780 (Fax) jgill@austin

- criminallawyer.com State Bar No. 24043692 ATTORNEY FOR APPELLANT

CERTIFICATE OF SERVICE I hereby certify that a true and correct copy of the foregoing Appellant’s First Motion
to Extend Time to File Brief was served on the Travis County District Attorney, P.O. Box 1748, Austin, Texas, 78767, by mail and electronic transmission (AppellateTCDA@co.travis.tx.us) , on this the 22 nd day of June , 2015

.

/s/ James Gill

______________ JAMES GILL
EXHIBIT 23.1

            CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

VA Software Corporation
Fremont, California

We  hereby  consent  to the  incorporation  by  reference  in  the  Registration
Statements on Form S-3 (No. 333-110841) and Form S-8 (Nos. 333-92409; 333-92391;
333-38768;  333-38766;   333-38874;   333-59096;   333-71944;   333-101965;  and
333-116778)  of VA Software  Corporation  of our reports dated October 31, 2005,
relating  to the  consolidated  financial  statements  and  financial  statement
schedule,  and the effectiveness of VA Software  Corporation's  internal control
over financial reporting, which appears to this Annual Report on Form 10-K.


/s/ BDO Seidman, LLP

San Jose, California
October 31, 2005




                                       77
Case 1:07-cv-03553-VM     Document 12      Filed 03/07/2008     Page 1 of 3

Case 1:07-cv-03553-VM     Document 12      Filed 03/07/2008     Page 2 of 3

Case 1:07-cv-03553-VM     Document 12      Filed 03/07/2008     Page 3 of 3
EXHIBIT 32.1

        JOINT CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER AND PRINCIPAL
            FINANCIAL OFFICER REQUIRED BY EXCHANGE ACT RULE 13A-14(B)

         In connection with the Annual Report of OmniCorder Technologies, Inc.
(the "Company") on Form 10-KSB for the year ended December 31, 2003 as filed
with the Securities and Exchange Commission (the "Report"), we, Mark A. Fauci,
President and Chief Executive Officer, and Steven W. Albanese, Controller and
Principal Financial Officer, certify, pursuant to 18 U.S.C. ss. 1350, as adopted
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

         1.       The Report fully complies with the requirements of section
                  13(a) or 15(d) of the Securities Exchange Act of 1934; and

         2.       The information contained in the Report fairly presents, in
                  all material respects, the financial condition and results of
                  operations of the Company.

April 8, 2004

                                    /s/ Mark A. Fauci
                                    ---------------------------------
                                    Mark A. Fauci
                                    President and Chief Executive Officer


                                    /s/ Steven W. Albanese
                                    ---------------------------------
                                    Steven W. Albanese
                                    Controller and Principal Financial Officer